Biology, Epidemiology, Clinical Aspects of Hepatocellular Carcinoma and the Role of Sorafenib

E-ISSN： 1873-5592|17|7|783-799

ISSN： 1389-4501

Source： Current Drug Targets, Vol.17, Iss.7, 2016-06, pp. : 783-799

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sorafenib: activity and clinical application in patients with hepatocellular carcinoma

By Guan Yong-Song He Qing

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 2, 2011-02 ,pp. : 303-313

Informa Healthcare

Access to resources Recommend Favorite

Clinical Application of Sorafenib for Treating Hepatocellular Carcinoma and Beyond

Clinical Cancer Drugs, Vol. 2, Iss. 2, 2015-10 ,pp. : 128-137

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Application of Sorafenib for Treating Hepatocellular Carcinoma and Beyond

Clinical Cancer Drugs, Vol. 2, Iss. 2, 2015-11 ,pp. : 128-137

Bentham Science Publishers

Access to resources Recommend Favorite

Sorafenib: In Hepatocellular Carcinoma

By Simpson Dene Keating Gillian M.

Drugs, Vol. 68, Iss. 2, 2008-01 ,pp. : 251-258

Adis International

Access to resources Recommend Favorite

Sorafenib (BAY 43-9006) in Hepatocellular Carcinoma Patients: From Discovery to Clinical Development

Current Medicinal Chemistry, Vol. 19, Iss. 7, 2012-03 ,pp. : 938-944

Bentham Science Publishers

Access to resources Recommend Favorite